SAMHD1 and glioblastoma: As shown in Supplementary Figure S3E, gID50 VLP(+Vpx)-mediated SAMHD1 depletion and CRISPR-mediated knockout resulted in an approximately 2-fold increase in the dNTP pool, comparable to non-GBM cancer cell line [23].